Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Zev D Schuman-Olivier, M.D.

Co-Author

This page shows the publications co-authored by Zev Schuman-Olivier and Mark Albanese.
Connection Strength

1.690
  1. Emerging adult age status predicts poor buprenorphine treatment retention. J Subst Abuse Treat. 2014 Sep; 47(3):202-12.
    View in: PubMed
    Score: 0.593
  2. Benzodiazepine use during buprenorphine treatment for opioid dependence: clinical and safety outcomes. Drug Alcohol Depend. 2013 Oct 01; 132(3):580-6.
    View in: PubMed
    Score: 0.553
  3. Building a Group-Based Opioid Treatment (GBOT) blueprint: a qualitative study delineating GBOT implementation. Addict Sci Clin Pract. 2019 12 27; 14(1):47.
    View in: PubMed
    Score: 0.218
  4. Implementing group visits for opioid use disorder: A case series. Subst Abus. 2020; 41(2):174-180.
    View in: PubMed
    Score: 0.213
  5. Self-treatment: illicit buprenorphine use by opioid-dependent treatment seekers. J Subst Abuse Treat. 2010 Jul; 39(1):41-50.
    View in: PubMed
    Score: 0.113
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.